TP53 and hepatocellular carcinoma: With respect to the mutated genes in HCC, the group with higher TTLL4 expression had higher mutation rates of TP53 (30%), MUC16 (23%), and CSMD3 (13%) than did the lower TTLL4 expression group [Fig. 2(a)].